Provided by Tiger Fintech (Singapore) Pte. Ltd.

CASI Pharmaceuticals

2.00
-0.0850-4.09%
Post-market: 1.95-0.0450-2.26%16:00 EDT
Volume:5.78K
Turnover:11.47K
Market Cap:30.91M
PE:-0.78
High:2.08
Open:2.08
Low:1.92
Close:2.08
Loading ...
May 25, 2022

Major Issues Report

8-K - Current report
May 25, 2022

Major Issues Report

8-K - Current report
May 24, 2022

Major Issues Report

8-K - Current report
May 24, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 16, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 20, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 13, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments